Sundar.M
☆    

India,
2019-02-15 14:37
(1886 d 18:25 ago)

Posting: # 19925
Views: 1,785
 

 Dose curve [PK / PD]

Post reply
Dear all,

How to choose dose for any PK/PD study (without non-clinical data) in healthy volunteer for Phase-1 trials for already marketed product? Other words, how to choose the proposed dose to detect clinically meaningful differences in PK/PD responses?

Thanks for your help.

Thanks
MSMN
 
UA Flag
Activity
 Admin contact
22,984 posts in 4,822 threads, 1,651 registered users;
49 visitors (0 registered, 49 guests [including 4 identified bots]).
Forum time: 10:03 CEST (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5